A phase II study of rucaparib in patients with high genomic LOH and/or BRCA 1/2 mutated stage IV non-small cell lung cancer (Lung-MAP Sub-Study, S1900A).
In: Journal of clinical oncology, Jg. 39 (2021), Heft 15 suppl, S. 9024-9024
Online
serialPeriodical
Zugriff:
Titel: |
A phase II study of rucaparib in patients with high genomic LOH and/or BRCA 1/2 mutated stage IV non-small cell lung cancer (Lung-MAP Sub-Study, S1900A).
|
---|---|
Autor/in / Beteiligte Person: | Riess, Jonathan W. ; Redman, Mary Weber ; Wheatley-Price, Paul ; Faller, Bryan A. ; Villaruz, Liza C. ; Corum, Larry R. ; Gowda, Aruna C. ; Srkalovic, Gordan ; Osarogiagbon, Raymond U. ; Baumgart, Megan Ann ; Qian, Lu ; Minichiello, Katherine ; Gandara, David R. ; Herbst, Roy S. ; Kelly, Karen |
Link: | |
Zeitschrift: | Journal of clinical oncology, Jg. 39 (2021), Heft 15 suppl, S. 9024-9024 |
Veröffentlichung: | 2021 |
Medientyp: | serialPeriodical |
ISSN: | 0732-183X (print) |
Sonstiges: |
|